Experimental tissue regeneration by DDS technology of bio-signaling molecules

Journal of Dermatological Science

Volumn 47, Issue 3, 2007, Pages 189-199

  Kimura, Yu ^a   Tabata, Yasuhiko ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Drug delivery system (DDS); Growth factor; Plasmid DNA; Release technology; Tissue regeneration

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BONE MORPHOGENETIC PROTEIN 2; CONNECTIVE TISSUE GROWTH FACTOR; GROWTH FACTOR; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; ARTICULAR CARTILAGE; BONE DEFECT; BONE DEVELOPMENT; CELL TRANSPLANTATION; CHONDROGENESIS; DRUG DELIVERY SYSTEM; ENZYME DEFICIENCY; HAIR GROWTH; HEART MUSCLE CELL; HEPATOCYTE TRANSPLANTATION; KIDNEY EPITHELIUM; LANGERHANS CELL; LIMB ISCHEMIA; NERVE REGENERATION; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; TISSUE REGENERATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOTECHNOLOGY; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; RATS; REGENERATION; REGENERATIVE MEDICINE; SKIN, ARTIFICIAL; TISSUE ENGINEERING; WOUND HEALING;

EID: 34447507662     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2007.04.002     Document Type: Review

References (71)

1. Langer R., and Vacanti J.P. Tissue engineering. Science 260 (1993) 920-926
2. Levenberg S., and Langer R. Advances in tissue engineering. Curr Top Dev Biol 61 (2004) 113-134
3. Bach A.D., Stem-Straeter J., Beier J.P., Bannasch H., and Stark G.B. Engineering of muscle tissue. Clin Plast Surg 30 (2003) 589-599
4. Bannasch H., Fohn M., Unterberg T., Bach A.D., Weyand B., and Stark G.B. Skin tissue engineering. Clin Plast Surg 30 (2003) 573-579
5. Chen R.R., and Mooney D.J. Polymeric growth factor delivery strategies for tissue engineering. Pharm Res 20 (2003) 1103-1112
6. Hubbell J.A. Tissue and cell engineering. Curr Opin Biotechnol 15 (2004) 381-382
7. Ikada Y. Challenges in tissue engineering. J R Soc Interface 3 (2006) 589-601
8. Lutolf M.P., and Hubbell J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23 (2005) 47-55
9. Silva E.A., and Mooney D.J. Synthetic extracellular matrices for tissue engineering and regeneration. Curr Top Dev Biol 64 (2004) 181-205
10. Vacanti C.A. History of tissue engineering and a glimpse into its future. Tissue Eng 12 (2006) 1137-1142
11. Ohlstein B., Kai T., Decotto E., and Spradling A. The stem cell niche: theme and variations. Curr Opin Cell Biol 16 (2004) 693-699
12. Ehrenreich M., and Ruszczak Z. Update on tissue-engineered biological dressings. Tissue Eng 12 (2006) 2407-2424
13. Rozga J. Liver support technology--an update. Xenotransplantation 13 (2006) 380-389
14. Wang H.L., Greenwell H., Fiorellini J., Giannobile W., Offenbacher S., Salkin L., et al. Periodontal regeneration. J Periodontol 76 (2005) 1601-1622
15. Yannas I.V., and Burke J.F. Design of an artificial skin. I. Basic design principles. J Biomed Mater Res 14 (1980) 65-81
16. Tabata Y. Significance of biomaterials and drug delivery systems in tissue engineering. Connective Tissue 33 (2001) 315-324
17. Rifkin D.B., and Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 109 (1989) 1-6
18. Ikada Y., and Tabata Y. Protein release from gelatin matrices. Adv Drug Deliv Rev 31 (1998) 287-301
19. Marui A., Kanematsu A., Yamahara K., Doi K., Kushibiki T., Yamamoto M., et al. Simultaneous application of basic fibroblast growth factor and hepatocyte growth factor to enhance the blood vessels formation. J Vasc Surg 41 (2005) 82-90
20. Iwakura A., Fujita M., Kataoka K., Tambara K., Sakakibara Y., Komeda M., et al. Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model. Heart Vessels 18 (2003) 93-99
21. Nakajima H., Sakakibara Y., Tambara K., Iwakura A., Doi K., Marui A., et al. Therapeutic angiogenesis by the controlled release of basic fibroblast growth factor for ischemic limb and heart injury: toward safety and minimal invasiveness. J Artif Organs 7 (2004) 58-61
22. Balamurugan A.N., Gu Y., Tabata Y., Miyamoto M., Cui W., Hori H., et al. Bioartificial pancreas transplantation at prevascularized intermuscular space: effect of angiogenesis induction on islet survival. Pancreas 26 (2003) 279-285
23. Sakakibara Y., Nishimura K., Tambara K., Yamamoto M., Lu F., Tabata Y., et al. Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation. J Thorac Cardiovasc Surg 124 (2002) 50-56
24. Saito A., Kazama J.J., Iino N., Cho K., Sato N., Yamazaki H., et al. Bioengineered implantation of megalin-expressing cells: a potential intracorporeal therapeutic model for uremic toxin protein clearance in renal failure. J Am Soc Nephrol 14 (2003) 2025-2032
25. Tabata Y., Hong L., Miyamoto S., Miyao M., Hashimoto N., and Ikada Y. Bone formation at a rabbit skull defect by autologous bone marrow cells combined with gelatin microspheres containing TGF-beta1. J Biomater Sci Polym Ed 11 (2000) 891-901
26. Iwakura A., Tabata Y., Tamura N., Doi K., Nishimura K., Nakamura T., et al. Gelatin sheet incorporating basic fibroblast growth factor enhances healing of devascularized sternum in diabetic rats. Circulation 104 (2001) I325-I329
27. Kimura Y., Ozeki M., Inamoto T., and Tabata Y. Adipose tissue engineering based on human preadipocytes combined with gelatin microspheres containing basic fibroblast growth factor. Biomaterials 24 (2003) 2513-2521
28. Kushibiki T., and Tabata Y. A new gene delivery system based on controlled release technology. Curr Drug Deliv 1 (2004) 153-163
29. Kushibiki T., Tomoshige R., Fukunaka Y., Kakemi M., and Tabata Y. In vivo release and gene expression of plasmid DNA by hydrogels of gelatin with different cationization extents. J Control Release 90 (2003) 207-216
30. Kushibiki T., Nagata-Nakajima N., Sugai M., Shimizu A., and Tabata Y. Enhanced anti-fibrotic activity of plasmid DNA expressing small interference rna for tgf-beta type ii receptor for a mouse model of obstructive nephropathy by cationized gelatin prepared from different amine compounds. J Control Release 110 (2006) 610-617
31. Yamamoto M., and Tabata Y. Tissue engineering by modulated gene delivery. Adv Drug Deliv Rev 58 (2006) 535-554
32. Kasahara H., Tanaka E., Fukuyama N., Sato E., Sakamoto H., Tabata Y., et al. Biodegradable gelatin hydrogel potentiates the angiogenic effect of fibroblast growth factor 4 plasmid in rabbit hindlimb ischemia. J Am Coll Cardiol 41 (2003) 1056-1062
33. Nagaya N., Kangawa K., Kanda M., Uematsu M., Horio T., Fukuyama N., et al. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Circulation 108 (2003) 889-895
34. Yannas I.V. Facts and theories of induced organ regeneration. Adv Biochem Eng Biotechnol 93 (2005) 1-38
35. Yannas I.V. Similarities and differences between induced organ regeneration in adults and early foetal regeneration. J R Soc Interface 2 (2005) 403-417
36. Itoh M., Hiraoka Y., Kataoka K., Huh N.H., Tabata Y., and Okochi H:. Novel collagen sponge reinforced with polyglycolic acid fiber produces robust, normal hair in murine hair reconstitution model. Tissue Eng 10 (2004) 818-824
37. Matsumoto G., Kushibiki T., Kinoshita Y., Lee U., Omi Y., Kubota E., et al. Cationized gelatin delivery of a plasmid DNA expressing small interference rna for vegf inhibits murine squamous cell carcinoma. Cancer Sci 97 (2006) 313-321
38. Ozeki M., and Tabata Y. Promoted growth of murine hair follicles through controlled release of basic fibroblast growth factor. Tissue Eng 8 (2002) 359-366
39. Ozeki M., and Tabata Y. Promoted growth of murine hair follicles through controlled release of vascular endothelial growth factor. Biomaterials 23 (2002) 2367-2373
40. Kawai K., Suzuki S., Tabata Y., Ikada Y., and Nishimura Y. Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis. Biomaterials 21 (2000) 489-499
41. Kawai K., Suzuki S., Tabata Y., and Nishimura Y. Accelerated wound healing through the incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis using a pressure-induced decubitus ulcer model in genetically diabetic mice. Br J Plast Surg 58 (2005) 1115-1123
42. Zhao Y., Shimizu T., Nishihira J., Koyama Y., Kushibiki T., Honda A., et al. Tissue regeneration using macrophage migration inhibitory factor-impregnated gelatin microbeads in cutaneous wounds. Am J Pathol 167 (2005) 1519-1529
43. Yoshida S., Yamaguchi Y., Itami S., Yoshikawa K., Tabata Y., Matsumoto K., et al. Neutralization of hepatocyte growth factor leads to retarded cutaneous wound healing associated with decreased neovascularization and granulation tissue formation. J Invest Dermatol 120 (2003) 335-343
44. Tsuji-saso Y, Kawazoe T, Morimoto N, Tabata Y, Taira T, Tomihata K, et al. Incorporation of basic fibroblast growth factor into preconfluent cultured skin substitute to accelerate neovascularisation and skin reconstruction after transplantation. Scand J Plast Reconstr Surg Hand Surg, in press.
45. Iimuro Y., Nishio T., Morimoto T., Nitta T., Stefanovic B., Choi S.K., et al. Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology 124 (2003) 445-458
46. Aoyama T., Yamamoto S., Kanematsu A., Ogawa O., and Tabata Y. Local delivery of matrix metalloproteinase gene prevents the onset of renal sclerosis in streptozotocin-induced diabetic mice. Tissue Eng 9 (2003) 1289-1299
47. Kushibiki T., Nagata-Nakajima N., Sugai M., Shimizu A., and Tabata Y. Delivery of plasmid DNA expressing small interference rna for tgf-beta type ii receptor by cationized gelatin to prevent interstitial renal fibrosis. J Control Release 105 (2005) 318-331
48. Miyazaki M., Obata Y., Abe K., Furusu A., Koji T., Tabata Y., et al. Gene transfer using nonviral delivery systems. Perit Dial Int 26 (2006) 633-640
49. Oe S., Fukunaka Y., Hirose T., Yamaoka Y., and Tabata Y. A trial on regeneration therapy of rat liver cirrhosis by controlled release of hepatocyte growth factor. J Control Release 88 (2003) 193-200
50. Wang W., Gu Y., Tabata Y., Miyamoto M., Hori H., Nagata N., et al. Reversal of diabetes in mice by xenotransplantation of a bioartificial pancreas in a prevascularized subcutaneous site. Transplantation 73 (2002) 122-129
51. Sakurai T., Satake A., Sumi S., Inoue K., Nagata N., Tabata Y., et al. The efficient prevascularization induced by fibroblast growth factor 2 with a collagen-coated device improves the cell survival of a bioartificial pancreas. Pancreas 28 (2004) e70-e79
52. Ogawa K., Asonuma K., Inomata Y., Kim I., Ikada Y., Tabata Y., et al. The efficacy of prevascularization by basic fgf for hepatocyte transplantation using polymer devices in rats. Cell Transplant 10 (2001) 723-729
53. Sakakibara Y., Tambara K., Sakaguchi G., Lu F., Yamamoto M., Nishimura K., et al. Toward surgical angiogenesis using slow-released basic fibroblast growth factor. Eur J Cardiothorac Surg 24 (2003) 105-111 [discussion 112]
54. Iwakura A., Tabata Y., Miyao M., Ozeki M., Tamura N., Ikai A., et al. Novel method to enhance sternal healing after harvesting bilateral internal thoracic arteries with use of basic fibroblast growth factor. Circulation 102 (2000) III307-III311
55. Iwakura A., Tabata Y., Koyama T., Doi K., Nishimura K., Kataoka K., et al. Gelatin sheet incorporating basic fibroblast growth factor enhances sternal healing after harvesting bilateral internal thoracic arteries. J Thorac Cardiovasc Surg 126 (2003) 1113-1120
56. Yamada K., Tabata Y., Yamamoto K., Miyamoto S., Nagata I., Kikuchi H., et al. Potential efficacy of basic fibroblast growth factor incorporated in biodegradable hydrogels for skull bone regeneration. J Neurosurg 86 (1997) 871-875
57. Tabata Y., Yamada K., Hong L., Miyamoto S., Hashimoto N., and Ikada Y. Skull bone regeneration in primates in response to basic fibroblast growth factor. J Neurosurg 91 (1999) 851-856
58. Ozeki M., and Tabata Y. In vivo promoted growth of mice hair follicles by the controlled release of growth factors. Biomaterials 24 (2003) 2387-2394
59. Nakahara T., Nakamura T., Kobayashi E., Inoue M., Shigeno K., Tabata Y., et al. Novel approach to regeneration of periodontal tissues based on in situ tissue engineering: effects of controlled release of basic fibroblast growth factor from a sandwich membrane. Tissue Eng 9 (2003) 153-162
60. Mligiliche N.L., Tabata Y., and Ide C. Nerve regeneration through biodegradable gelatin conduits in mice. East Afr Med J 76 (1999) 400-406
61. Yokota S., Kinoshita Y., Fukuoka S., Mizunuma H., Ozono S., Tabata Y., et al. Tissue engineering in jawbone-potential efficacy of bfgf-incorporated gelatin microspheres for bone formation of mandibular defects. J Jpn Stomatol Soc 51 (2002) 324-334
62. Hong L., Tabata Y., Miyamoto S., Yamada K., Aoyama I., Tamura M., et al. Promoted bone healing at a rabbit skull gap between autologous bone fragment and the surrounding intact bone with biodegradable microspheres containing transforming growth factor-beta1. Tissue Eng 6 (2000) 331-340
63. Hong L., Miyamoto S., Hashimoto N., and Tabata Y. Synergistic effect of gelatin microspheres incorporating tgf-beta1 and a physical barrier for fibrous tissue infiltration on skull bone formation. J Biomater Sci Polym Ed 11 (2000) 1357-1369
64. Hong L., Tabata Y., Miyamoto S., Yamamoto M., Yamada K., Hashimoto N., et al. Bone regeneration at rabbit skull defects treated with transforming growth factor-beta1 incorporated into hydrogels with different levels of biodegradability. J Neurosurg 92 (2000) 315-325
65. Yamamoto M., Tabata Y., Hong L., Miyamoto S., Hashimoto N., and Ikada Y. Bone regeneration by transforming growth factor beta1 released from a biodegradable hydrogel. J Control Release 64 (2000) 133-142
66. Kojima K., Ignotz R.A., Kushibiki T., Tinsley K.W., Tabata Y., and Vacanti C.A. Tissue-engineered trachea from sheep marrow stromal cells with transforming growth factor beta2 released from biodegradable microspheres in a nude rat recipient. J Thorac Cardiovasc Surg 128 (2004) 147-153
67. Nishida T., Kubota S., Kojima S., Kuboki T., Nakao K., Kushibiki T., et al. Regeneration of defects in articular cartilage in rat knee joints by ccn2 (connective tissue growth factor). J Bone Miner Res 19 (2004) 1308-1319
68. Hong L., Tabata Y., Yamamoto M., Miyamoto S., Yamada K., Hashimoto N., et al. Comparison of bone regeneration in a rabbit skull defect by recombinant human bmp-2 incorporated in biodegradable hydrogel and in solution. J Biomater Sci Polym Ed 9 (1998) 1014
69. Okamoto T., Yamamoto Y., Gotoh M., Huang C.L., Nakamura T., Shimizu Y., et al. Slow release of bone morphogenetic protein 2 from a gelatin sponge to promote regeneration of tracheal cartilage in a canine model. J Thorac Cardiovasc Surg 127 (2004) 329-334
70. Ueda H., Hong L., Yamamoto M., Shigeno K., Inoue M., Toba T., et al. Use of collagen sponge incorporating transforming growth factor-beta1 to promote bone repair in skull defects in rabbits. Biomaterials 23 (2002) 1010
71. Tabata Y., Miyao M., Ozeki M., and Ikada Y. Controlled release of vascular endothelial growth factor by use of collagen hydrogels. J Biomater Sci Polym Ed 11 (2000) 915-930